Myolex
Nan-Wei Gong is a prominent entrepreneur and researcher with extensive experience in health technology and engineering. As the Founder and CEO of FIGUR8, Inc. since January 2017, Nan-Wei leads the development of an innovative biomotion Assessment Platform that enhances musculoskeletal health and recovery insights. In addition to this role, Nan-Wei serves as a Research Affiliate at MIT Media Lab and holds board positions at MassMEDIC, BioPro Scientific, and Myolex. Previously, Nan-Wei was the Research Development Lead at Google ATAP and founded Circular2 Inc., an engineering consulting firm. Early career includes co-founding 3dim Tech, Inc. based on MIT technologies and completing a PhD at the Massachusetts Institute of Technology.
This person is not in the org chart
This person is not in any teams
Myolex
Myolex is disrupting how to measure muscle wasting (and treatment), caused by obesity drugs, aging, and sport injuries. Myolex® EIM is a patented device technology and SaaS data analytics platform that is built to disrupt skeletal muscle measurement by becoming the clinical and wellness standard to aid in the diagnosis and treatment of obesity drug and age-related muscle wasting. Myolex has developed the 1st quantitative, sensitive, painless, portable for home use muscle quality assessment device that is specifically designed to non-invasively, comprehensibly, and precisely detect and monitor single muscle wasting.